Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

3 treatments under study, led by Ferrous Sulfate

Research Leaders

7 sponsors active, led by University of Toronto

Related Conditions

Often studied with 12 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 65/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results50% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 4 (1)

Trial Status

Unknown1
Active Not Recruiting1
Terminated1
Completed1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Ferrous Sulfate2
  • No Intervention But Exposure1
  • Psg1

Active Sponsors

  • University of Toronto1
  • Hugo W. Moser Research Institute at Kennedy Krieger, Inc.1
  • University of Western Ontario, Canada1
  • Ottawa Hospital Research Institute1
  • University of Ottawa1

Top Investigators

Related Conditions

  • Restless Legs Syndrome3
  • Irondeficiency2
  • Sleep Apnea Syndromes1
  • Adhd1
  • Opioid Use1

Activity Timeline